Philadelphia Eye Associates Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Mark
Blecher, M.D. at Philadelphia
Eye Associates in Philadelphia, Pa., is participating in the
AcuFocus clinical study for the IC-8 intraocular lens (IOL)
designed for patients with cataracts.

“Participating in clinical studies has almost an immeasurable value for
me and my team,” said Dr. Blecher. “It helps us with our mission to
deliver personalized vision care and transformative vision solutions.
That is why we are so excited as we begin to enroll patients in this
important cataract study.”

By the age of 65, an estimated 90% of people worldwide experience
changes to the natural crystalline lens of the eye. The lens gradually
becomes cloudy as a cataract develops leading to blurry vision and
eventually vision loss. The only solution to a cataract is the surgical
removal of the natural lens and its replacement with an artificial lens
called an IOL. More than 25 million cataract procedures are performed
worldwide each year. The majority of patients with cataracts are treated
with a standard monofocal (single-focus) lens, which allows the patient
to have excellent far vision; however, patients remain dependent on
glasses for near and intermediate vision.

Dr. Blecher will be one of a select group of clinical investigators
across the United States for the IC-8
lens study. The IC-8 lens is a clear monofocal lens with a
mini-ring placed in the center. The mini-ring has an opening, or
pinhole, designed to increase the range of vision by extending the focus
of light rays that enter the eye. The clinical study will determine if
the IC-8 lens in one eye, when paired with a standard monofocal
lens in the other eye, will provide near and intermediate vision in
addition to far vision for cataract patients.

Philadelphia Eye Associates is now enrolling patients that meet the
study eligibility criteria. Patients who comply with study commitments
will be compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing and able to participate in examinations and all
  follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens
clinical study, please contact Lisa Flynn at Philadelphia Eye Associates
at 800-448-6767 ext. 1115 or at [email protected].

ABOUT US

Philadelphia
Eye Associates is proud to be a division of Vantage EyeCare,
the largest comprehensive provider of eye care and state of the art eye
surgery in the region. Philly Eye has four offices and seven doctors
offering the most advanced cataract, cornea, diabetic and cosmetic eye
care. The IC-8 IOL clinical study will be performed through our South
Philadelphia location.

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company
that develops and markets breakthrough technologies for the improvement
of vision. The IC-8 lens received its CE mark in 2014 and is available
in select markets across Europe and Asia. Founded in 2001, AcuFocus is
based in Irvine, Calif. For additional information about the IC-8
intraocular lens, visit www.ic8lensclinicalstudy.com
or https://www.facebook.com/ic8lensclinicalstudy.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005277/en/